HomeME • NASDAQ
add
23andMe Holding Co.
$0.39
Makalipas ang Oras ng Trabaho:(5.55%)+0.022
$0.41
Sarado: Hun 28, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$0.42
Sakop ng araw
$0.39 - $0.44
Sakop ng taon
$0.35 - $2.03
Market cap
183.57M USD
Average na Volume
4.49M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 64.03M | -30.69% |
Gastos sa pagpapatakbo | 53.15M | -51.42% |
Net na kita | -208.83M | -225.80% |
Net profit margin | -326.16 | -370.04% |
Kita sa bawat share | -0.43 | -206.96% |
EBITDA | -22.06M | 64.57% |
Aktuwal na % ng binabayarang buwis | -0.01% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 216.49M | -44.04% |
Kabuuang asset | 395.17M | -58.08% |
Kabuuang sagutin | 206.65M | -9.63% |
Kabuuang equity | 188.52M | — |
Natitirang share | 490.26M | — |
Presyo para makapag-book | 1.11 | — |
Return on assets | -13.02% | — |
Return on capital | -18.11% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | -208.83M | -225.80% |
Cash mula sa mga operasyon | -25.78M | 42.65% |
Cash mula sa pag-invest | -2.15M | 34.73% |
Cash mula sa financing | 2.00M | -23.25% |
Net change in cash | -25.93M | 43.57% |
Malayang cash flow | 50.88M | 282.19% |
Tungkol
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Itinatag
Abr 2006
Headquarters
Website
Mga Empleyado
571